TrialDiabetes, obesity & metabolism2021

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).

Arndís F Ólafsdóttir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.